Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms LPA 81 |
Target |
Mechanism Bcr-Abl modulators(Bcr-Abl tyrosine kinase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Philadelphia chromosome positive chronic myelogenous leukemia | Preclinical | US | 09 Dec 2022 |